PlainRecalls
FDA Drug Low Class III Terminated

Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603

Reported: November 20, 2019 Initiated: October 1, 2019 #D-0322-2020

Product Description

Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603

Reason for Recall

Subpotent Drug

Details

Recalling Firm
Sato Pharmaceutical Inc.
Units Affected
21,864 units
Distribution
Nationwide within the United States, Guam and Saipan
Location
Torrance, CA

Frequently Asked Questions

What product was recalled?
Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603. Recalled by Sato Pharmaceutical Inc.. Units affected: 21,864 units.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on November 20, 2019. Severity: Low. Recall number: D-0322-2020.